華潤醫療(01515.HK)附屬與復康醫院簽訂醫療設備採購協議 涉資1,337萬人幣
華潤醫療(01515.HK)公佈,於上週五(25日),全資附屬益生永信作爲賣方與復康醫院簽訂醫療設備採購協議,益生永信將據此向復康醫院出售多項醫療設備,金額爲人民幣1,337.46萬元人民幣。相關之醫療設備包括理療牀、多種肢體復康訓練設備、吞嚥障礙治療儀、步態分析和平衡測試系統、認知康復訓練軟件及其他基礎訓練設備等。
復康醫院自本年3月中籤署相關協議以來已委託集團管理,本次交易因應復康醫院之實際需求,由益生永信保證了醫院運營的所需設備能及時到位,以確保復康醫院開業後相關科室能儘快開始運營。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.